Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate the clinical course and risk factors for VAT and the impact of VAT on Intensive Care Unit (ICU) morbidity and mortality.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VAT patients | Patients developing Ventilator Associated Tracheobronchitis | ||
| VAP | Patients presenting ventilator associated pneumonia | ||
| No ventilator associated infection | patients who do not present ventilator associated infection during their stay in ICU |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| mortality | we assessed mortality from all causes at 4 weeks | mortality at 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| ICU length of stay | expected average length of stay 15 days | |
| mortality at 6 months | 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
ICU patients ventilated > 48hours
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
blood, sputum